Detalhe da pesquisa
1.
SIX2 promotes cell plasticity via Wnt/ß-catenin signalling in androgen receptor independent prostate cancer.
Nucleic Acids Res
; 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554106
2.
Microglial amyloid beta clearance is driven by PIEZO1 channels.
J Neuroinflammation
; 19(1): 147, 2022 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35706029
3.
Using online game-based platforms to improve student performance and engagement in histology teaching.
BMC Med Educ
; 19(1): 273, 2019 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331319
4.
DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2.
Commun Biol
; 7(1): 108, 2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238517
5.
Fanconi anemia pathway regulation by FANCI in prostate cancer.
Front Oncol
; 13: 1260826, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023254
6.
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.
Am J Pathol
; 178(2): 525-36, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21281786
7.
M1 Macrophages Induce Protumor Inflammation in Melanoma Cells through TNFR-NF-κB Signaling.
J Invest Dermatol
; 142(11): 3041-3051.e10, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35580697
8.
Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression.
Cancers (Basel)
; 13(4)2021 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33572108
9.
Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.
Cancer Res
; 81(19): 4901-4909, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348967
10.
Thermal dose as a universal tool to evaluate nanoparticle-induced photothermal therapy.
Int J Pharm
; 587: 119657, 2020 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682960
11.
BCOR-coupled H2A monoubiquitination represses a subset of androgen receptor target genes regulating prostate cancer proliferation.
Oncogene
; 39(11): 2391-2407, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31925334
12.
CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.
Cells
; 8(3)2019 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30909497
13.
Axon Guidance-Related Factor FLRT3 Regulates VEGF-Signaling and Endothelial Cell Function.
Front Physiol
; 10: 224, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930791
14.
The ß2-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells.
Mol Cancer Res
; 17(11): 2154-2168, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395667
15.
Targeting Prostate Cancer Subtype 1 by Forkhead Box M1 Pathway Inhibition.
Clin Cancer Res
; 23(22): 6923-6933, 2017 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28899970
16.
The Master Neural Transcription Factor BRN2 Is an Androgen Receptor-Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer.
Cancer Discov
; 7(1): 54-71, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784708
17.
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.
J Mol Biochem
; 5(1): 12-22, 2016 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27891324
18.
Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.
Endocr Relat Cancer
; 22(3): R165-82, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934687
19.
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.
Oncotarget
; 4(1): 48-63, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23295955
20.
A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care.
Oncotarget
; 4(4): 502-30, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23594434